Catalyst Pharmaceuticals Inc (CPRX)

12:18 PM

Catalyst Pharmaceuticals jumps on report of interest from Angelini Pharma (CPRX:NASDAQ) - Seeking Alpha

12:18 PM

12:13 PM

Catalyst Pharmaceuticals stock surges on takeover report By Investing.com - Investing.com Canada

12:13 PM

12:04 PM

Italy’s Angelini Said to Explore Acquisition of Catalyst Pharma - Bloomberg

12:04 PM

11:03 AM

Catalyst Pharmaceuticals Jumps 6.8% Amid Sector-Wide Rally - AlphaStreet

11:03 AM

Apr 26, 2026

Catalyst Pharma: Favorable Trial Outcome Could Be A Meaningful Overhang (CPRX) - Seeking Alpha

Apr 26, 2026

Apr 25, 2026

Should Stronger Firdapse and Agamree Momentum Require Action From Catalyst Pharmaceuticals (CPRX) Investors? - Sahm

Apr 25, 2026

Apr 24, 2026

How Rare-Disease Drug Momentum At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story - Yahoo Finance

Apr 24, 2026

Apr 24, 2026

Catalyst Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 24, 2026

Apr 24, 2026

From Sun Belt Boom to Biotech Hub: Why Southern Florida’s Moment has Arrived - Pharmaceutical Executive

Apr 24, 2026

Apr 24, 2026

Catalyst Pharmaceuticals stock hits all-time high at $26.63 By Investing.com - Investing.com Australia

Apr 24, 2026

Apr 23, 2026

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 23, 2026

Apr 23, 2026

Catalyst Pharmaceuticals (NASDAQ:CPRX) Sets New 1-Year HighHere's What Happened - MarketBeat

Apr 23, 2026

Apr 23, 2026

Catalyst Pharmaceuticals stock hits all-time high at $26.63 - Investing.com

Apr 23, 2026

Apr 23, 2026

Is Catalyst (CPRX) stock attracting cautious sentiment | Q4 2025: Better Than ExpectedReal Time Stock Idea Network - Xã Thanh Hà

Apr 23, 2026

Apr 23, 2026

CPRX Stock Price, Quote & Chart | CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) - ChartMill

Apr 23, 2026

Apr 22, 2026

Catalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 22, 2026

Apr 22, 2026

The Bull Case For Catalyst Pharmaceuticals (CPRX) Could Change Following Firdapse Exclusivity Win And Agamree Launch - Sahm

Apr 22, 2026

Apr 21, 2026

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Average Recommendation of "Strong Buy" from Brokerages - MarketBeat

Apr 21, 2026

Apr 20, 2026

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data - TradingView

Apr 20, 2026

Apr 20, 2026

Price-Driven Insight from (CPRX) for Rule-Based Strategy - Stock Traders Daily

Apr 20, 2026

Apr 19, 2026

Catalyst Pharmaceuticals (CPRX) Is Up 5.3% After Stronger Revenue And Expanded M&A PipelineWhat's Changed - Sahm

Apr 19, 2026

Apr 18, 2026

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Presents a Compelling Value Investment Case - ChartMill

Apr 18, 2026

Apr 17, 2026

Catalyst Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 17, 2026

Apr 17, 2026

Institutional Support And Deal Pipeline Shape Outlook For Catalyst Pharmaceuticals - Yahoo Finance

Apr 17, 2026

Apr 16, 2026

Theravance Stock Declines Around 17% in Three Months: Here's Why - TradingView

Apr 16, 2026

Apr 16, 2026

NTLA Stock Rises 20% in 3 Months: Here's What You Should Know - TradingView

Apr 16, 2026

Apr 15, 2026

Catalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 15, 2026

Apr 15, 2026

See How Institutions Boost Catalyst Shares - Yahoo Finance Australia

Apr 15, 2026

Apr 15, 2026

Best Momentum Stock to Buy for March 4th - Eastern Progress

Apr 15, 2026

Apr 14, 2026

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Strength - Yahoo Finance

Apr 14, 2026

Apr 14, 2026

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Strong Growth Stock with a Positive Technical Setup - ChartMill

Apr 14, 2026

Apr 13, 2026

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now - MSN

Apr 13, 2026

Apr 13, 2026

Gains Recap: Is Catalyst Pharmaceuticals Incs growth already priced inMarket Trend Report & Verified Technical Signals - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Jim Cramer on Catalyst Pharmaceuticals: "It's a very inexpensive stock" - MSN

Apr 12, 2026

Apr 11, 2026

SG Americas Securities LLC Has $765,000 Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Apr 11, 2026

Apr 10, 2026

Catalyst Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 10, 2026

Apr 10, 2026

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200 - TradingView — Track All Markets

Apr 10, 2026

Apr 10, 2026

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Emerges as a Top Affordable Growth Stock - ChartMill

Apr 10, 2026

Apr 09, 2026

Price Action: Will Catalyst Pharmaceuticals Inc benefit from government policy2026 Trading Volume Trends & Reliable Price Breakout Signals - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know - TradingView — Track All Markets

Apr 09, 2026

Apr 09, 2026

(CPRX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 09, 2026

Apr 08, 2026

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum - Sahm

Apr 08, 2026

Apr 07, 2026

Bear Alert: Is Catalyst Pharmaceuticals Inc currently under institutional pressure2026 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Extending Firdapse Exclusivity And Launching AgamreeHas The Bull Case Changed? - Yahoo Finance

Apr 07, 2026

Apr 06, 2026

Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics - Bitget

Apr 06, 2026

Apr 06, 2026

IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints - TradingView — Track All Markets

Apr 06, 2026

Apr 06, 2026

Catalyst Pharmaceuticals, Inc. (CPRX) stock price, news, quote and history - Yahoo Finance UK

Apr 06, 2026

Apr 06, 2026

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - The Globe and Mail

Apr 06, 2026